Submit Deal

Submit Deal

Cover Image Chris Hollowood

Chris Hollowood

CEO at SYNCONA LTD

Manager

Deal Bio

Total Deals8

Valued Deals8

Total Value£ 1.02 B

Avg. Deal Size£ 128 M

Market Context

Sort

04 Mar 2019|United Kingdom|Biotechnology

Target: NIGHTSTAR THERAPEUTICS

Bidder: BIOGEN INC

8 Service Providers

5 Target | 3 Bidder

30 Dealmakers

27 Target | 4 Bidder

£ 663 M

Value

16 Mar 2020|United Kingdom|Biotechnology

Target: FREELINE THERAPEUTICS

Bidder: WELLINGTON MANAGEMENT

8 Service Providers

2 Target | 6 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 91 M

Value

18 May 2022|United States|Biotechnology

Target: SWANBIO THERAPEUTICS

Bidder: SYNCONA LTD

4 Service Providers

1 Target | 3 Bidder

10 Dealmakers

3 Target | 7 Bidder

£ 45 M

Value

24 Oct 2022|United States|Biotechnology

Target: APPLIED GENETIC TECHNOLOGIES CORPORATION

Bidder: SYNCONA LTD

9 Service Providers

5 Target | 4 Bidder

9 Dealmakers

2 Target | 7 Bidder

£ 64 M

Value

12 Jun 2023|United States|Health Care Services

Target: BEACON THERAPEUTICS

Bidder: SYNCONA LTD

3 Service Providers

1 Target | 2 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 96 M

Value

22 Nov 2023|United Kingdom|Biotechnology

Target: FREELINE THERAPEUTICS

Bidder: SYNCONA LTD

6 Service Providers

2 Target | 4 Bidder

6 Dealmakers

£ 11 M

Value

11 Apr 2024|United States|Biotechnology

Target: CLADE THERAPEUTICS

Bidder: CENTURY THERAPEUTICS

6 Service Providers

1 Target | 3 Bidder | 2 Vendor

20 Dealmakers

14 Target | 1 Bidder | 5 Vendor

£ 35 M

Value

20 Jun 2024|United Kingdom|Biotechnology

Target: YELLOWSTONE BIOSCIENCES

Bidder: SYNCONA LTD

3 Service Providers

1 Target | 2 Bidder

7 Dealmakers

1 Target | 6 Bidder

£ 16 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Chris Hollowood